 Visiogen’s board and investment team is comprised of leading experts in the fields of ophthalmology and healthcare technology and include:
Rodney D. Altman, M.D.
Senior Partner CMEA Ventures Jeani Delagardelle
Managing Director New Leaf Venture Partners Andrew D. Firlik, M.D.
General Partner Foundation Medical Partners John Gilbert
Former President of IOLAB, a Johnson & Johnson Company Russell Hirsch, M.D.
Managing Director Prospect Venture Partners Richard Lin, M.D.
Partner Three Arch Partners Roger J. Quy PhD
General Partner Technology Partners Steven D. Weinstein
Managing Director Novartis Venture Funds Reza Zadno, Ph.D.
President and CEO Visiogen, Inc. |
